Evidence map›Paper›PMID 39478441›Full record

ArticleBMC medical research methodology2024

Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis.

Shady Abdelsalam, Paul A Agius, Rachel Sacks-Davis, Amanda Roxburgh, Michael Livingston, Lisa Maher, Matthew Hickman, Paul Dietze

Abstract read
In one paragraph

Article in BMC medical research methodology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shady AbdelsalamNational Drug Research Institute (NDRI), Faculty of Health Sciences, Curtin University, Melbourne, Australia.
Paul A AgiusDisease Elimination Head, Alcohol and other Drug Research, Burnet Institute, Melbourne, Australia.
Rachel Sacks-DavisDisease Elimination Head, Alcohol and other Drug Research, Burnet Institute, Melbourne, Australia.
Amanda RoxburghDisease Elimination Head, Alcohol and other Drug Research, Burnet Institute, Melbourne, Australia.
Michael LivingstonNational Drug Research Institute (NDRI), Faculty of Health Sciences, Curtin University, Melbourne, Australia.
Lisa MaherDisease Elimination Head, Alcohol and other Drug Research, Burnet Institute, Melbourne, Australia.
Matthew HickmanDisease Elimination Head, Alcohol and other Drug Research, Burnet Institute, Melbourne, Australia.
Paul DietzeNational Drug Research Institute (NDRI), Faculty of Health Sciences, Curtin University, Melbourne, Australia. pauld@burnet.edu.au.

Funding

National Health and Medical Research Council 545891 & 1126090
6 · The paper itself

Abstract

backgroundCompared to the general population, people who inject drugs have poor health and wellbeing. Longitudinal studies can provide insight into factors driving these worse health outcomes but are subject to methodological challenges, such as cohort attrition. The aim of this study was to assess and characterise attrition in a prospective cohort of people who inject drugs in Victoria, Australia.

methodsUsing annually collected self-reported data from The Melbourne Injecting Drug User Cohort Study (SuperMIX) from September 2008 to January 2021, we estimated the incidence of participants being lost-to-follow-up (LTFU), with an episode of being LTFU defined as participants not undertaking a follow-up interview within two years of their last interview. We utilised a multiple event discrete-time survival analysis on participant period-observation data to estimate the associations between key factors and LTFU. Key areas of exposure measurement in analyses were sociodemographic, drug use and mental health.

resultsA total of n = 1328 SuperMIX participants completed a baseline interview, with n = 489 (36.8%) LTFU, i.e. not completing a follow-up interview in the following two years. Increased attrition was observed among SuperMIX participants who were: born outside Australia, younger than 30 years, reporting having completed fewer years of education, not residing in stable accommodation, not in stable employment and not on opioid agonist therapy (OAT).

conclusionsThe attrition rate of the SuperMIX cohort has largely been stable throughout the duration of the study. Higher attrition rates among individuals at greater sociodemographic disadvantage and not on OAT suggest that additional efforts are required to retain these participants. Findings also suggest that SuperMIX might not be capturing data on adverse health and wellbeing outcomes among subpopulations at high risk of harm.

Indexed as

Substance Abuse, IntravenousAdultCohort StudiesDrug UsersFemaleHumansLongitudinal StudiesLost to Follow-UpMaleMental HealthMiddle AgedProspective StudiesSelf ReportSurvival AnalysisVictoriaYoung AdultCohort attritionCohort studiesLost to follow upPeople who inject drugs

Identifiers

PMID39478441
PMCPMC11523591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.